NEW YORK, Aug. 31, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Engility Holdings, Inc. EGL, SLM Corporation SLM, Kraton Corporation KRA, AAC Holdings, Inc. AAC, Array BioPharma Inc. ARRY, and Symantec Corporation SYMC, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
EGL DOWNLOAD: http://Fundamental-Markets.com/register/?so=EGL
SLM DOWNLOAD: http://Fundamental-Markets.com/register/?so=SLM
KRA DOWNLOAD: http://Fundamental-Markets.com/register/?so=KRA
AAC DOWNLOAD: http://Fundamental-Markets.com/register/?so=AAC
ARRY DOWNLOAD: http://Fundamental-Markets.com/register/?so=ARRY
SYMC DOWNLOAD: http://Fundamental-Markets.com/register/?so=SYMC
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Engility Holdings, Inc. EGL, SLM Corporation SLM, Kraton Corporation KRA, AAC Holdings, Inc. AAC, Array BioPharma Inc. ARRY, and Symantec Corporation SYMC on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 29th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
ENGILITY HOLDINGS, INC. (EGL) REPORT OVERVIEW
Engility's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Engility reported revenue of $488.51MM vs $494.67MM (down 1.24%) and basic earnings per share $0.32 vs $0.21 (up 52.38%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Engility reported revenue of $1,931.89MM vs $2,076.42MM (down 6.96%) and basic earnings per share -$0.96 vs -$0.29. Engility is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.62. The estimated EPS forecast for the next fiscal year is $2.15 and is expected to report on March 7th, 2019.
To read the full Engility Holdings, Inc. (EGL) report, download it here: http://Fundamental-Markets.com/register/?so=EGL
-----------------------------------------
SLM CORPORATION (SLM) REPORT OVERVIEW
SLM's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, SLM reported interest income of $462.31MM vs $342.10MM (up 35.14%) and basic earnings per share $0.24 vs $0.15 (up 60.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, SLM reported interest income of $1,437.30MM vs $1,077.25MM (up 33.42%) and basic earnings per share $0.63 vs $0.54 (up 16.67%). SLM is expected to report earnings on October 17th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.17. The estimated EPS forecast for the next fiscal year is $1.20 and is expected to report on January 16th, 2019.
To read the full SLM Corporation (SLM) report, download it here: http://Fundamental-Markets.com/register/?so=SLM
-----------------------------------------
KRATON CORPORATION (KRA) REPORT OVERVIEW
Kraton's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Kraton reported revenue of $538.40MM vs $525.32MM (up 2.49%) and basic earnings per share -$0.47 vs $0.82. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Kraton reported revenue of $1,960.36MM vs $1,744.10MM (up 12.40%) and basic earnings per share $3.12 vs $3.48 (down 10.34%). Kraton is expected to report earnings on October 23rd, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $1.51. The estimated EPS forecast for the next fiscal year is $4.68 and is expected to report on February 19th, 2019.
To read the full Kraton Corporation (KRA) report, download it here: http://Fundamental-Markets.com/register/?so=KRA
-----------------------------------------
AAC HOLDINGS, INC. (AAC) REPORT OVERVIEW
AAC's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, AAC reported revenue of $86.76MM vs $78.04MM (up 11.17%) and basic earnings per share -$0.12 vs -$0.08. For the twelve months ended December 31st, 2017 vs December 31st, 2016, AAC reported revenue of $317.64MM vs $279.77MM (up 13.54%) and basic earnings per share -$0.88 vs -$0.03. AAC is expected to report earnings on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.12. The estimated EPS forecast for the next fiscal year is $0.95 and is expected to report on February 20th, 2019.
To read the full AAC Holdings, Inc. (AAC) report, download it here: http://Fundamental-Markets.com/register/?so=AAC
-----------------------------------------
ARRAY BIOPHARMA INC. (ARRY) REPORT OVERVIEW
Array BioPharma's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Array BioPharma reported revenue of $35.44MM vs $33.78MM (up 4.91%) and basic earnings per share -$0.24 vs -$0.17. For the twelve months ended June 30th, 2018 vs June 30th, 2017, Array BioPharma reported revenue of $173.77MM vs $150.85MM (up 15.19%) and basic earnings per share -$0.74 vs -$0.72. Array BioPharma is expected to report earnings on October 30th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.22. The estimated EPS forecast for the next fiscal year is -$0.41 and is expected to report on August 13th, 2019.
To read the full Array BioPharma Inc. (ARRY) report, download it here: http://Fundamental-Markets.com/register/?so=ARRY
-----------------------------------------
SYMANTEC CORPORATION (SYMC) REPORT OVERVIEW
Symantec's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Symantec reported revenue of $1,156.00MM vs $1,175.00MM (down 1.62%) and basic earnings per share -$0.10 vs -$0.22. For the twelve months ended March 31st, 2018 vs March 31st, 2017, Symantec reported revenue of $4,846.00MM vs $4,019.00MM (up 20.58%) and basic earnings per share $1.89 vs -$0.17. Symantec is expected to report earnings on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.21. The estimated EPS forecast for the next fiscal year is $1.10 and is expected to report on May 9th, 2019.
To read the full Symantec Corporation (SYMC) report, download it here: http://Fundamental-Markets.com/register/?so=SYMC
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
